Vistagen Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | — | — | $201.0K |
| FY2011 | $18.7M | $323.6K | $139.3K |
| FY2012 | $6.0M | $341.6K | $81.0K |
| FY2013 | $13.4M | $881.5K | $638.1K |
| FY2014 | $13.1M | $263.7K | — |
| FY2015 | $20.8M | $269.7K | $70.0K |
| FY2016 | $4.0M | $989.8K | $428.5K |
| FY2017 | $3.1M | $3.7M | $2.9M |
| FY2018 | $4.4M | $11.3M | $10.4M |
| FY2019 | $6.9M | $14.0M | $13.1M |
| FY2020 | $11.5M | $5.8M | $1.4M |
| FY2021 | $16.3M | $108.3M | $103.1M |
| FY2022 | $9.9M | $74.6M | $68.1M |
| FY2023 | $9.0M | $21.1M | $16.6M |
| FY2024 | $9.4M | $123.7M | $119.2M |
| FY2025 | $14.0M | $84.3M | $67.1M |
| FY2026 | $13.0M | $48.6M | $30.8M |